Patents by Inventor Mark HURTIG

Mark HURTIG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
    Patent number: 11865205
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: January 9, 2024
    Assignee: MEDINCELL S.A.
    Inventors: Georges Gaudriault, Sylvestre Grizot, Mark Hurtig, Matthew Shive
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20240000703
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 4, 2024
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20210322302
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: January 25, 2021
    Publication date: October 21, 2021
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20200155449
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 21, 2020
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE